NASDAQ · Healthcare · Biotechnology
Compass Therapeutics, Inc.
CMPX
Compass Therapeutics, Inc. CEO Thomas J. Schuetz · Market cap $253.1M.
$1.83
+0.00 · +0.00%
52w hi $6.8852w lo $1.61
Off 52w high 72.0%
63
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $11.20
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Apr 29 | Neil Lerner | Chief Accounting Officer | Buy | 15,000 | $1.89 | +$28K | 57 |
| Apr 29 | Jonathan Anderman | General Counsel | Buy | 25,000 | $1.89 | +$47K | 63 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay